Circulating cell-free micro-RNA as biomarkers: From myocardial infarction to hypertension

Research output: Contribution to journalReview articlepeer-review

Abstract

MicroRNA (miRNA) are small, single strand non-coding RNA molecules involved in the post-transcriptional regulation of target genes. Since their discovery in 1993, over 2000 miRNAs have been identified in humans and there is growing interest in both the diagnostic and therapeutic potential of miRNA. The identification of biomarkers for human disease progression remains an active area of research, and there is a growing number of miRNA and miRNA combinations that have been linked to the development and progression of numerous cardiovascular diseases, including hypertension. In 2010, Chen et al. reported in Clinical Science that cell-free circulating miRNA could serve as novel biomarkers for acute myocardial infarction [1]. In this commentary, we expand on this topic to discuss the potential of using miRNA as biomarkers for hypertension and hypertension-related end-organ damage.

Original languageEnglish (US)
Pages (from-to)1341-1346
Number of pages6
JournalClinical Science
Volume136
Issue number18
DOIs
StatePublished - Sep 2022

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Circulating cell-free micro-RNA as biomarkers: From myocardial infarction to hypertension'. Together they form a unique fingerprint.

Cite this